These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 18363524)
1. A comparison of pentane-1,5-diol to other diols for use in dermatology. Sundberg JJ; Faergemann J Expert Opin Investig Drugs; 2008 Apr; 17(4):601-10. PubMed ID: 18363524 [TBL] [Abstract][Full Text] [Related]
3. Effect of pentane-1,5-diol and propane-1,2-diol on percutaneous absorption of terbinafine. Evenbratt H; Faergemann J Acta Derm Venereol; 2009; 89(2):126-9. PubMed ID: 19325994 [TBL] [Abstract][Full Text] [Related]
4. The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage? Faergemann J; Hedner T; Larsson P Acta Derm Venereol; 2005; 85(3):203-5. PubMed ID: 16040402 [TBL] [Abstract][Full Text] [Related]
5. The antimycotic activity in vitro of five diols. Faergemann J; Fredriksson T Sabouraudia; 1980 Dec; 18(4):287-93. PubMed ID: 7455861 [TBL] [Abstract][Full Text] [Related]
6. Safety assessment of 1,2-glycols as used in cosmetics. Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler D; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA Int J Toxicol; 2012; 31(5 Suppl):147S-68S. PubMed ID: 23064773 [TBL] [Abstract][Full Text] [Related]
7. Dermal absorption and hydrolysis of methylparaben in different vehicles through intact and damaged skin: using a pig-ear model in vitro. Pažoureková S; Hojerová J; Klimová Z; Lucová M Food Chem Toxicol; 2013 Sep; 59():754-65. PubMed ID: 23872132 [TBL] [Abstract][Full Text] [Related]
8. S2k guidelines for the use of topical preparations on the skin. Wohlrab J; Staubach P; Augustin M; Eisert L; Hünerbein A; Nast A; Reimann H; Strömer K; Mahler V J Dtsch Dermatol Ges; 2018 Mar; 16(3):376-392. PubMed ID: 29537159 [TBL] [Abstract][Full Text] [Related]
9. Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance. Jackson JM; Pelle M J Drugs Dermatol; 2011 Jun; 10(6):627-33. PubMed ID: 21637903 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives. Shaughnessy CN; Malajian D; Belsito DV J Am Acad Dermatol; 2014 Jan; 70(1):102-7. PubMed ID: 24220722 [TBL] [Abstract][Full Text] [Related]
16. Dermatologic treatment during pregnancy: practical overview. Al Hammadi A; Al-Haddab M; Sasseville D J Cutan Med Surg; 2006; 10(4):183-92. PubMed ID: 17234117 [TBL] [Abstract][Full Text] [Related]
17. [Excipients and new topical forms in dermatology]. Delattre L J Pharm Belg; 1993; 48(4):261-9. PubMed ID: 8410631 [No Abstract] [Full Text] [Related]
18. Ophthalmic preservatives: focus on polyquaternium-1. Rolando M; Crider JY; Kahook MY Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766 [TBL] [Abstract][Full Text] [Related]
19. The critical role of the vehicle to therapeutic efficacy and patient compliance. Piacquadio D; Kligman A J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S67-73. PubMed ID: 9703127 [No Abstract] [Full Text] [Related]
20. 1H NMR spectra of butane-1,4-diol and other 1,4-diols: DFT calculation of shifts and coupling constants. Lomas JS Magn Reson Chem; 2014 Mar; 52(3):87-97. PubMed ID: 24519848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]